Navigation Links
Taming microbes to combat antibiotic resistance
Date:2/25/2014

LOS ANGELES (Feb. 25, 2014) With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.

Michael Yeaman, PhD, an LA BioMed researcher, recently received an Innovation Award for $1.6 million from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) to develop novel anti-infectives designed to disarm methicillin-resistant S. aureus (MRSA) and reduce its resistance to antibiotics.

"Real-time adaptations in microbes that drive antibiotic treatment failures are known but have been poorly understood," Dr. Yeaman said. "Our approach interferes with the adaptations MRSA uses to survive in the body. Enhancing the effectiveness of existing antibiotics and minimizing resistance by dangerous microbes like MRSA are public health priorities directly addressed by our research."

Dangerous microbes that have survived traditional antibiotics now threaten to cause untreatable infections.

"Antibiotic resistance is a predictable result of microbial survival instincts in the face of drugs that are designed to kill them," Dr. Yeaman said. "New variations on old antibiotics may work in the short term, but inevitably microbes, such as MRSA, adapt to resist even the newest forms of conventional drugs. By fundamentally changing our approach, we are exploring totally new ways to tame the microbes and slow their resistance."

The U.S. Centers for Disease Control and Prevention (CDC) estimate that more than 2 million Americans suffer from antibiotic resistant infections per year. More than 20,000 die from drug-resistant infections annually, and countless more undergo costly and prolonged hospital stays and exposure to ineffective antibiotics. Ironically, these conditions promote further drug resistance. Estimated costs of drug-resistant infections to the healthcare system range as high as $20 billion per year in the U.S. alone with up to $35 billion in additional costs to society for lost productivity, according to the CDC.

This innovative research program includes LA BioMed researchers, Arnold Bayer, MD, and Yan Q. Xiong, MD, PhD. It builds on discoveries already patented by members of the team, and it leverages strategic anti-inflammatory drugs already approved by the Food and Drug Administration.

"Ultimately, results from this program may accelerate pre-clinical and clinical studies of new anti-infective combinations to improve treatment outcomes in life-threatening MRSA and other infections," Dr. Yeaman said. "Our program may also be able to avoid the prohibitive time and cost typical for discovery and development of new drugs and bring novel anti-infectives to market more quickly to address the significant and growing public health threat of antibiotic-resistant infections."


'/>"/>

Contact: Laura Mecoy
lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. Taming physical forces that block cancer treatment
2. Scientists Probe Diversity of Human Bodys Microbes
3. Gut Microbes Might Reflect Health, Diet of Older Adults
4. Weapon-wielding marine microbes may protect populations from foes
5. University of Tennessee study: Unexpected microbes fighting harmful greenhouse gas
6. New biochip technology uses tiny whirlpools to corral microbes
7. Through New Innovative Measures, Highly Pathogenic Microbes Will Now Be Tested Clinically, Strengthening The Front Line In The Fight Against Food-Borne Illness
8. New Technology Automatically Sterilizes Dangerous Microbes at Point of Sale Terminals
9. Gut microbes may be a risk factor for colorectal cancer
10. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
11. For Combat Vets, Brain Injury Symptoms Can Last Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Permobil has just completed ... of custom seating systems has a well-earned reputation for premium quality, with a ... innovation and growth in the custom seating business, which enjoys strong demand, and ...
(Date:1/16/2017)... CA (PRWEB) , ... January 16, 2017 , ... ... manuscript in the Aesthetic Surgery Journal , the official journal of The ... conducted on lower eyelid retraction surgery. The procedure is designed to correct drooping, ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... NexTec Group ... a group of 100 organizations honored for their accomplishments in the field of midmarket ... growth, industry leadership and recognition, and innovation. Selection is not based on revenue and ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music themed ... and ease," said Christina Austin - CEO of Pixel Film Studios. , On ... edit the style and animation of their slideshows. Place each slide on top of ...
(Date:1/14/2017)... ... 2017 , ... Healthy living brand Moody Zook recently came ... With more and more people opting to go organic in their lifestyle, the ... to specific needs. , Moody Zook focused particularly on their newly launched activated ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Stock-Callers is currently reviewing the following Medical Appliances ... WMGI ), Varian Medical Systems Inc. (NYSE: VAR ... NuVasive Inc. (NASDAQ: NUVA ). These companies belong ... finish on Thursday, January 12 th , 2017, with the ... health care companies in the S&P 500 were down less ...
(Date:1/13/2017)... , Jan. 13, 2017  Alfalfa, cattle, leafy greens and ... environmental sampling film , which emphasizes the food industry,s shift ... highlights how COPAN,s Swab Rinse Kit ... the surface sampling process in the wake of the new ... COPAN is expanding the U.S. production ...
(Date:1/13/2017)... 13, 2017 On Thursday, January ... Average, and the S&P 500 edged lower at the ... trading session in bearish territories. Taking into consideration yesterday,s ... this morning: Myriad Genetics Inc. (NASDAQ: MYGN ... Research Holdings Inc. (NASDAQ: INCR ), and ...
Breaking Medicine Technology: